{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:29:02Z","timestamp":1787056142065,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300767"],"award-info":[{"award-number":["82300767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260150"],"award-info":[{"award-number":["82260150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100705"],"award-info":[{"award-number":["82100705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112729","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:35:57Z","timestamp":1783524957000},"page":"112729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SGLT2 inhibition attenuates diabetes-induced lipid nephrotoxicity by targeting SOAT1-mediated cholesterol metabolism in proximal tubular cells"],"prefix":"10.1016","volume":"147","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2026.112729_bb0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2026.112729_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ebiom.2019.09.002","article-title":"FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease","volume":"48","author":"Huang","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112729_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112729_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.kint.2020.08.012","article-title":"Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes","volume":"99","author":"Ueki","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2026.112729_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104778","article-title":"Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis","volume":"156","author":"Su","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"36","key":"10.1016\/j.cellsig.2026.112729_bb0030","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.2174\/0929867328666210419132807","article-title":"The role of cholesterol homeostasis in diabetic kidney disease","volume":"28","author":"Chen","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112729_bb0035","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112729_bb0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/15384101.2022.2031429","article-title":"Dapagliflozin attenuates cholesterol overloading-induced injury in mice hepatocytes with type 2 diabetes mellitus (T2DM) via eliminating oxidative damages","volume":"21","author":"Yang","year":"2022","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112729_bb0045","first-page":"3625","article-title":"Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1-receptor for advanced glycation end products-nuclear factor-kappaB signaling pathway","volume":"18","author":"Yao","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112729_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s11255-020-02481-3","article-title":"A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin","volume":"52","author":"Eleftheriadis","year":"2020","journal-title":"Int. Urol. Nephrol."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112729_bb0055","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1021\/acs.jmedchem.2c01265","article-title":"Targeting sterol O-acyltransferase\/acyl-CoA:cholesterol acyltransferase (ACAT): a perspective on small-molecule inhibitors and their therapeutic potential","volume":"65","author":"Bhattacharjee","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112729_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1197502","article-title":"Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy","volume":"13","author":"Tu","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112729_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/JME-20-0079","article-title":"Circ-Tulp4 promotes beta-cell adaptation to lipotoxicity by regulating soat1 expression","volume":"65","author":"Wu","year":"2020","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112729_bb0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2020.06.040","article-title":"Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome","volume":"98","author":"Liu","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2026.112729_bb0075","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83353","article-title":"Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome","volume":"12","author":"Ge","year":"2023","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112729_bb0080","doi-asserted-by":"crossref","first-page":"F476","DOI":"10.1152\/ajprenal.00363.2006","article-title":"A primary culture of mouse proximal tubular cells, established on collagen-coated membranes","volume":"293","author":"Terryn","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2026.112729_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-9136-5_11","article-title":"Intracellular and plasma membrane cholesterol labeling and quantification using Filipin and GFP-D4","volume":"1949","author":"Wilhelm","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112729_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1210\/endrev\/bnz010","article-title":"The new biology of diabetic kidney disease-mechanisms and therapeutic implications","volume":"41","author":"Lytvyn","year":"2020","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112729_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","article-title":"The tubular hypothesis of nephron filtration and diabetic kidney disease","volume":"16","author":"Vallon","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112729_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111857","article-title":"Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis","volume":"22","author":"Hung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112729_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165654","article-title":"Molecular pathways that drive diabetic kidney disease","volume":"133","author":"Mohandes","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112729_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112729_bb0115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","article-title":"Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis","volume":"27","author":"Lovisa","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112729_bb0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1681\/ASN.2021101293","article-title":"Mechanisms and models of kidney tubular necrosis and nephron loss","volume":"33","author":"Maremonti","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112729_bb0125","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1681\/ASN.2019020163","article-title":"Sirtuin 5 regulates proximal tubule fatty acid oxidation to protect against AKI","volume":"30","author":"Chiba","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112729_bb0130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","article-title":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease","volume":"33","author":"Mori","year":"2021","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112729_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107969","article-title":"Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease","volume":"35","author":"de Araujo Lira","year":"2021","journal-title":"J. Diabetes Complicat."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112729_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18364","article-title":"Molecular mechanism of renal lipid accumulation in diabetic kidney disease","volume":"28","author":"Fang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112729_bb0145","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/dmrr.2546","article-title":"Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients","volume":"30","author":"Kim","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"7838","key":"10.1016\/j.cellsig.2026.112729_bb0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","article-title":"Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112729_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.kint.2018.10.038","article-title":"Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy","volume":"95","author":"Chen","year":"2019","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112729_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphs.2021.11.005","article-title":"ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis","volume":"148","author":"Matsuo","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2026.112729_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155377","article-title":"ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease","volume":"139","author":"Zhang","year":"2023","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112729_bb0170","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1038\/s41598-023-35499-5","article-title":"ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1\/IRF1 axis in diabetic kidney disease","volume":"13","author":"Ito","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112729_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112729_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10020-022-00545-x","article-title":"PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease","volume":"28","author":"Zhao","year":"2022","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112729_bb0185","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1172\/JCI85939","article-title":"Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury","volume":"126","author":"Pedigo","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112729_bb0190","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.32518","article-title":"P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis","volume":"77","author":"Zhu","year":"2023","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.cellsig.2026.112729_bb0195","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1158\/1078-0432.CCR-15-2973","article-title":"Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis","volume":"22","author":"Geng","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112729_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115962","article-title":"TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury","volume":"170","author":"Wei","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112729_bb0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201646119","article-title":"Acat1\/Soat1 knockout extends the mutant Npc1 mouse lifespan and ameliorates functional deficiencies in multiple organelles of mutant cells","volume":"119","author":"Rogers","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"43","key":"10.1016\/j.cellsig.2026.112729_bb0210","doi-asserted-by":"crossref","first-page":"15836","DOI":"10.1074\/jbc.RA119.010564","article-title":"Myeloid Acat1\/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions","volume":"294","author":"Melton","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112729_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","article-title":"Kidney and heart failure outcomes associated with SGLT2 inhibitor use","volume":"18","author":"van der Aart-van der Beek","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2026.112729_bb0220","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cellsig.2026.112729_bb0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-med-042921-102135","article-title":"SGLT2 inhibitors: the sweet success for kidneys","volume":"74","author":"Dharia","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cellsig.2026.112729_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104215","article-title":"Cardiorenal protection of SGLT2 inhibitors-perspectives from metabolic reprogramming","volume":"83","author":"Gao","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112729_bb0235","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112729_bb0240","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.diabet.2017.04.002","article-title":"Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells","volume":"43","author":"Solini","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cellsig.2026.112729_bb0245","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.937766","article-title":"Programmed cell death in diabetic nephropathy: a review of apoptosis, autophagy, and necroptosis","volume":"28","author":"Erekat","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cellsig.2026.112729_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114562","article-title":"Targeting inflammation and necroptosis in diabetic kidney disease: a novel approach via PPARalpha modulation","volume":"154","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112729_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2438857","article-title":"Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through beta-hydroxybutyrate production","volume":"47","author":"Tian","year":"2025","journal-title":"Ren. Fail."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:42:03Z","timestamp":1787053323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S0898656826003864"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112729","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibition attenuates diabetes-induced lipid nephrotoxicity by targeting SOAT1-mediated cholesterol metabolism in proximal tubular cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112729"}}